Abbott clinical biochemical second-generation total bilirubin test group - Taiwan Registration 43649074541ab9815c5a3707ee4eaa8f
Access comprehensive regulatory information for Abbott clinical biochemical second-generation total bilirubin test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 43649074541ab9815c5a3707ee4eaa8f and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used to quantify total bilirubin in human serum or plasma in adults and newborns on the ARCHITECT c System.
A Clinical chemistry and clinical toxicology
A.1110 Bilirubin (total or direct) test system
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Oct 19, 2022
Oct 19, 2027

